Topic: Renal Cancer
May 25, 2005
Inhaled IL-2 Improves Five-Year Survival for Advanced Renal Cancer
An inhaled form of interleukin-2 was associated with a five-year survival rate of 21% in patients with renal cell carcinoma that had metastasized to the lungs
... morePosted at 2:55 PM | TrackBack (1)
